A detailed history of Black Rock Inc. transactions in Liquidia Corp stock. As of the latest transaction made, Black Rock Inc. holds 4,240,740 shares of LQDA stock, worth $48.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,240,740
Previous 3,747,491 13.16%
Holding current value
$48.9 Million
Previous $55.3 Million 7.94%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.96 - $15.71 $5.9 Million - $7.75 Million
493,249 Added 13.16%
4,240,740 $50.9 Million
Q1 2024

May 10, 2024

BUY
$11.35 - $16.73 $2.47 Million - $3.65 Million
218,030 Added 6.18%
3,747,491 $55.3 Million
Q4 2023

Feb 13, 2024

BUY
$5.77 - $12.19 $1.29 Million - $2.72 Million
222,882 Added 6.74%
3,529,461 $42.5 Million
Q3 2023

Nov 13, 2023

BUY
$6.27 - $8.15 $85,347 - $110,937
13,612 Added 0.41%
3,306,579 $21 Million
Q2 2023

Aug 11, 2023

BUY
$6.63 - $9.9 $359,743 - $537,174
54,260 Added 1.68%
3,292,967 $25.8 Million
Q1 2023

May 12, 2023

SELL
$5.72 - $7.91 $251,994 - $348,475
-44,055 Reduced 1.34%
3,238,707 $22.4 Million
Q4 2022

Feb 13, 2023

BUY
$4.68 - $6.54 $870,821 - $1.22 Million
186,073 Added 6.01%
3,282,762 $20.9 Million
Q3 2022

Nov 14, 2022

BUY
$3.73 - $8.39 $139,942 - $314,776
37,518 Added 1.23%
3,096,689 $16.8 Million
Q2 2022

Aug 12, 2022

BUY
$3.37 - $7.55 $7.46 Million - $16.7 Million
2,212,786 Added 261.44%
3,059,171 $13.3 Million
Q1 2022

May 12, 2022

BUY
$5.14 - $7.38 $15,635 - $22,449
3,042 Added 0.36%
846,385 $6.08 Million
Q4 2021

Feb 10, 2022

BUY
$2.71 - $5.17 $12,636 - $24,107
4,663 Added 0.56%
843,343 $4.11 Million
Q3 2021

Nov 09, 2021

SELL
$2.28 - $2.95 $19,195 - $24,836
-8,419 Reduced 0.99%
838,680 $2.32 Million
Q2 2021

Aug 11, 2021

BUY
$2.51 - $3.11 $2.13 Million - $2.63 Million
847,099 New
847,099 $2.42 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $742M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.